SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Reliq Health Technologies Inc
RHT.V 0.2150.0%Oct 28 9:30 AM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: pocotrader4/11/2018 9:40:22 PM
   of 658
 
Reliq Health Technologies (RHT.V) – setting expectations
themoneynarrative Company recommendations & reviews April 11, 2018 1 Minute
RHT.V has been making great progress with clients and getting patients onboard. News regarding newly added users has a significant impact upon the stock price. The company has also ramped up its sales force, and training of client staff, responsible for working directly with patients, is ongoing.

RHT.V’s sales pitch is pretty compelling. Not only is patient health care improved, but health care providers can expect to see a more robust bottom line. Governments can take credit for supporting technological solutions that are effective and economical.

Prospective clients increasingly will skip the pilot project phase of the evaluation. RHT.V’s technology has successfully passed several pilots, and many institutions will be prepared to rely upon the experience of their colleagues elsewhere.

While investors will continue to be pleased with the news flow and its positive impact upon the stock price, it is important to consider the company’s biggest opportunity: the National Health Service (NHS) in the United Kingdom (the world’s largest single-payer healthcare provider). The NHS and other big potential clients like Sacred Heart are great references and definitely help sales with other potential clients; however, their scale is also a major factor explaining their cautious and prolonged consideration of adoption of the technology.

While signing the NHS or another large healthcare provider to a major contract would be transformative for RHT.V, shareholders should understand that these developments can take years. Here at themoneynarrative we don’t mind the wait, since bringing smaller clients and their patients onboard is a lot easier task for RHT.V to handle now. By the time the major players are ready to sign, the company will be that much better positioned to respond to the challenges.




Share this:
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext